Oncoletter provides links to the AACR Press Releases relating to papers presented at the AACR Press Conference and in AACR Press Releases.
AACR website (subscription required)
ATI-450 – pancreatic cancer.
darolutamide – metastatic hormone sensitive prostate cancer.
mirvetuximab soravtansine – in ovarian cancer.
KB-0742 – in MYC-amplified solid tumors.
zandelisib – in relapsed/refractory follicular lymphoma.
OP-1250 – in ≥4-line ER+/HER2-negative breast cancer.
Compendium (d) Compendium (f)